Repeated aminoglycoside exposure activates interferon-stimulated genes in human renal proximal tubular models

Vidya Chandrasekaran1, Tamara Meijer1, Martin O Leonard2

  • 1Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, Amsterdam Institute of Molecular and Life Sciences (AIMMS), De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.

Insights

Aminoglycoside antibiotics like gentamicin and tobramycin cause kidney damage. This study reveals they trigger an innate immune response in human kidney cells, with primary cells showing a clearer response than cell lines.

Area of Science:

  • Nephrology
  • Toxicology
  • Molecular Biology

Background:

  • Aminoglycosides are vital antibiotics, but their use is restricted by nephrotoxicity.
  • The exact cellular mechanisms of aminoglycoside-induced kidney damage are not fully understood.
  • Megalin-mediated proximal tubular accumulation is a known factor, but downstream effects require further investigation.

Purpose of the Study:

  • To compare the transcriptomic responses of various human proximal tubular models to gentamicin and tobramycin.
  • To identify the specific cellular pathways involved in aminoglycoside-induced nephrotoxicity.
  • To determine which in vitro models are most suitable for studying these effects.

Main Methods:

  • Utilized primary proximal tubular epithelial cells (PTEC) and human iPSC-derived proximal tubular-like cells (PTL), alongside RPTEC/TERT1 and HK-2 cell lines.
  • Administered daily doses of gentamicin or tobramycin for seven days.
  • Assessed gene expression using the TempO-Seq EU-ToxRisk v2.1 panel and analyzed data with DESeq2.

Main Results:

  • Primary PTEC and PTL models exhibited strong, coherent transcriptional responses, notably inducing interferon-stimulated genes (ISGs).
  • Key ISGs induced include IFI27, IFI6, IFIT1-3, ISG15, MX1, and OAS1, indicating an innate immune-like response.
  • Tobramycin generally elicited a stronger transcriptional response than gentamicin; RPTEC/TERT1 and HK-2 cells showed less consistent results.

Conclusions:

  • Repeated aminoglycoside exposure induces a significant innate immune-like transcriptional signature in human proximal tubular cells.
  • Primary PTEC and PTL models are more informative for investigating the mechanisms of aminoglycoside nephrotoxicity compared to RPTEC/TERT1 and HK-2 cells.
  • The findings highlight the role of interferon signaling pathways in aminoglycoside-induced kidney damage.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...